Leprosy -- India
A World Health Organization survey of drug-resistant leprosy has detected 8 percent of samples tested in India resistant to rifampicin [also called rifampin in the U.S.], a drug used to treat the infection, leading to concerns that the country could fail to meet its target of completely eradicating the disease by 2020.
The global survey was carried out on new and relapsed cases reported between 2008-15 and shows the highest number of samples, apart from Brazil, that were resistant to the
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?5676657&promed&0
No comments:
Post a Comment